Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen K Wasan

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Lipids in Health and Disease|October 30, 2013
Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasisFady Ibrahim, Olena Sivak, Ellen K Wasan, et al.
Drug Development and Industrial Pharmacy|September 1, 2018
Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetilMunawar Mohammed, Holly Mansell, Ahmed Shoker, et al.
Drug Development and Industrial Pharmacy|August 30, 2014
Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperatureKishor M Wasan, Olena Sivak, Karen Bartlett, et al.
Drug Development and Industrial Pharmacy|July 5, 2017
Review and analysis of FDA approved drugs using lipid-based formulationsRonak Savla, Jeff Browne, Vincent Plassat, et al.
Pharmaceutical Research|November 7, 2006
A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft modelSebastian Cogswell, Stuart Berger, Dawn Waterhouse, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 29, 2012
Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis modelFady Ibrahim, Pavel Gershkovich, Olena Sivak, et al.
Pharmaceutics|November 22, 2017
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug DeliveryMunawar A Mohammed, Jaweria T M Syeda, Kishor M Wasan, et al.
International Journal of Pharmaceutics|July 10, 2012
Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasisFady Ibrahim, Pavel Gershkovich, Olena Sivak, et al.
Drug Development and Industrial Pharmacy|June 16, 2010
Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and SudanSheila J Thornton, Kishor M Wasan, Anna Piecuch, et al.
Advanced Drug Delivery Reviews|December 7, 2007
Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infectionsKristina Sachs-Barrable, Stephen D Lee, Ellen K Wasan, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Lipids in Health and Disease|October 30, 2013
Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasisFady Ibrahim, Olena Sivak, Ellen K Wasan, et al.
Drug Development and Industrial Pharmacy|September 1, 2018
Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetilMunawar Mohammed, Holly Mansell, Ahmed Shoker, et al.
Drug Development and Industrial Pharmacy|August 30, 2014
Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperatureKishor M Wasan, Olena Sivak, Karen Bartlett, et al.
Drug Development and Industrial Pharmacy|July 5, 2017
Review and analysis of FDA approved drugs using lipid-based formulationsRonak Savla, Jeff Browne, Vincent Plassat, et al.
Pharmaceutical Research|November 7, 2006
A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft modelSebastian Cogswell, Stuart Berger, Dawn Waterhouse, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 29, 2012
Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis modelFady Ibrahim, Pavel Gershkovich, Olena Sivak, et al.
Pharmaceutics|November 22, 2017
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug DeliveryMunawar A Mohammed, Jaweria T M Syeda, Kishor M Wasan, et al.
International Journal of Pharmaceutics|July 10, 2012
Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasisFady Ibrahim, Pavel Gershkovich, Olena Sivak, et al.
Drug Development and Industrial Pharmacy|June 16, 2010
Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and SudanSheila J Thornton, Kishor M Wasan, Anna Piecuch, et al.
Advanced Drug Delivery Reviews|December 7, 2007
Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infectionsKristina Sachs-Barrable, Stephen D Lee, Ellen K Wasan, et al.
Pageof 4